Corcept Therapeutics CORT Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's shares (basic)?
- Corcept Therapeutics (CORT) reported shares (basic) of 104.4M in Q1 2026.
- How has Corcept Therapeutics's shares (basic) changed year-over-year?
- Corcept Therapeutics's shares (basic) increased by 0.3% year-over-year, from 104.1M to 104.4M.
- What is the long-term trend for Corcept Therapeutics's shares (basic)?
- Over 4 years (2021 to 2025), Corcept Therapeutics's shares (basic) has grown at a -2.7% compound annual growth rate (CAGR), from 464.6M to 415.6M.
- What does shares (basic) mean?
- The average number of common shares held by investors throughout the reporting period.
- How do you interpret shares (basic)?
- An increase often signals share issuance for capital raising or employee compensation, while a decrease typically reflects share buyback programs. It provides context on the company's equity base and capital structure changes.
- How does shares (basic) compare across companies?
- Standardized metric used to normalize earnings across different periods and companies with varying share counts.